Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Targeted Medical Pharma, Inc. (TRGM) Starts Presentation at Annual Marcum MicroCap Conference

Targeted Medical Pharma, Inc. (OTCQB: TRGM) is a biotechnology company that develops prescription medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company manufactures 10 proprietary prescription-only medical foods, which it sells to physicians and pharmacies in the United States through its subsidiary, Physician Therapeutics. These proprietary medications focus on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs. For more information, visit the company’s website at www.tmedpharma.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.